Understanding how trypsin activates in pancreatitis
Mechanisms of Trypsin Activation in Pancreatitis
This study is looking at how a digestive enzyme called trypsin gets activated in the pancreas, which is an important step in the development of pancreatitis, to help find better ways to understand and treat people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11009499 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the digestive enzyme trypsin is activated in the pancreas, which is a critical early event in the development of pancreatitis. The study aims to clarify the roles of different activation pathways, including the potential influence of genetic mutations and the enzyme cathepsin B. By conducting experiments on animal models, the researchers will explore how these factors contribute to the severity and onset of pancreatitis. This knowledge could lead to better understanding and treatment options for patients suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of pancreatitis or those with genetic predispositions to the condition.
Not a fit: Patients who do not have pancreatitis or related digestive disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive strategies for pancreatitis, potentially reducing its severity and onset in affected patients.
How similar studies have performed: Previous research has shown promise in understanding enzyme activation in similar contexts, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Geisz-Fremy, Andrea — Boston University Medical Campus
- Study coordinator: Geisz-Fremy, Andrea
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.